[1] STAMM C, NASSERI B, HETZER R. Cardiac stem cells in patients with ischaemic cardiomyopathy. Lancet. 2012;379(9819):891.
[2] MAKKAR RR, SMITH RR, CHENG K, et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet. 2012;379(9819):895-904.
[3] URBANELLI L, BURATTA S, SAGINI K, et al. Exosome-based strategies for Diagnosis and Therapy. Recent Pat CNS Drug Discov. 2015;10(1):10-27.
[4] MÜLLER-EHMSEN J, WHITTAKER P, KLONER RA, et al. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol. 2002;34(2):107-116.
[5] PAGANI FD, DERSIMONIAN H, ZAWADZKA A, et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol. 2003;41(5):879-888.
[6] CAI H, LIN L, CAI H, et al. Prognostic evaluation of microRNA-210 expression in pediatric osteosarcoma. Med Oncol. 2013;30(2):499.
[7] KISHORE R, KHAN M. More Than Tiny Sacks: Stem Cell Exosomes as Cell-Free Modality for Cardiac Repair. Circ Res. 2016;118(2):330-343.
[8] KHAN M, KISHORE R. Stem Cell Exosomes: Cell-FreeTherapy for Organ Repair. Methods Mol Biol. 2017;1553:315-321.
[9] ZHANG Z, YANG J, YAN W, et al. Pretreatment of Cardiac Stem Cells With Exosomes Derived From Mesenchymal Stem Cells Enhances Myocardial Repair. J Am Heart Assoc. 2016;5(1):e002856.
[10] JUNG JH, FU X, YANG PC. Exosomes Generated From iPSC-Derivatives: New Direction for Stem Cell Therapy in Human Heart Diseases. Circ Res. 2017;120(2):407-417.
[11] BANG C, THUM T. Exosomes: new players in cell-cell communication. Int J Biochem Cell Biol. 2012;44(11):2060-2064.
[12] VALADI H, EKSTRÖM K, BOSSIOS A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9(6):654-659.
[13] FITZNER D, SCHNAARS M, VAN ROSSUM D, et al. Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis. J Cell Sci. 2011;124(Pt 3):447-458.
[14] COSTA VERDERA H, GITZ-FRANCOIS JJ, SCHIFFELERS RM, et al. Cellular uptake of extracellular vesicles is mediated by clathrin-independent endocytosis and macropinocytosis. J Control Release. 2017;266:100-108.
[15] PAROLINI I, FEDERICI C, RAGGI C, et al. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem. 2009; 284(49):34211-34222.
[16] LAI RC, ARSLAN F, LEE MM, et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 2010;4(3):214-222.
[17] PIRONTI G, STRACHAN RT, ABRAHAM D, et al. Circulating Exosomes Induced by Cardiac Pressure Overload Contain Functional Angiotensin II Type 1 Receptors. Circulation. 2015;131(24): 2120-2130.
[18] SEGURA E, GUÉRIN C, HOGG N, et al. CD8+ dendritic cells use LFA-1 to capture MHC-peptide complexes from exosomes in vivo. J Immunol. 2007;179(3):1489-1496.
[19] O'LOUGHLIN AJ, WOFFINDALE CA, WOOD MJ. Exosomes and the emerging field of exosome-based gene therapy. Curr Gene Ther. 2012;12(4):262-274.
[20] SKOG J, WÜRDINGER T, VAN RIJN S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol.2008;10(12):1470-1476.
[21] BACH FH, ALBERTINI RJ, JOO P, et al. Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet. 1968;2(7583): 1364-1366.
[22] SANGANALMATH SK, BOLLI R. Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ Res. 2013;113(6):810-834.
[23] GNECCHI M, ZHANG Z, NI A, et al. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res. 2008;103(11):1204-1219.
[24] SINGLA DK. Stem cells and exosomes in cardiac repair. Curr Opin Pharmacol. 2016;27:19-23.
[25] SUZUKI E, FUJITA D, TAKAHASHI M, et al. Stem cell-derived exosomes as a therapeutic tool for cardiovascular disease. World J Stem Cells. 2016;8(9):297-305.
[26] PRATHIPATI P, NANDI SS, MISHRA PK. Stem Cell-Derived Exosomes, Autophagy, Extracellular Matrix Turnover, and miRNAs in Cardiac Regeneration during Stem Cell Therapy. Stem Cell Rev Rep. 2017; 13(1):79-91.
[27] FREYMAN T, POLIN G, OSMAN H, et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J. 2006;27(9):1114-1122.
[28] ANGOULVANT D, IVANES F, FERRERA R, et al. Mesenchymal stem cell conditioned media attenuates in vitro and ex vivo myocardial reperfusion injury. J Heart Lung Transplant. 2011;30(1):95-102.
[29] SHAO L, ZHANG Y, LAN B, et al. MiRNA-Sequence Indicates That Mesenchymal Stem Cells and Exosomes Have Similar Mechanism to Enhance Cardiac Repair. Biomed Res Int. 2017;2017:4150705.
[30] FENG Y, HUANG W, WANI M, et al. Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22. PLoS One. 2014;9(2): e88685.
[31] YU B, KIM HW, GONG M, et al. Exosomes secreted from GATA-4 overexpressing mesenchymal stem cells serve as a reservoir of anti-apoptotic microRNAs for cardioprotection. Int J Cardiol. 2015;182: 349-360.
[32] BIAN S, ZHANG L, DUAN L, et al. Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model. J Mol Med (Berl). 2014;92(4): 387-397.
[33] TENG X, CHEN L, CHEN W, et al. Mesenchymal Stem Cell-Derived Exosomes Improve the Microenvironment of Infarcted Myocardium Contributing to Angiogenesis and Anti-Inflammation. Cell Physiol Biochem. 2015;37(6):2415-2424.
[34] FRANGOGIANNIS NG. The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol. 2014;11(5):255-265.
[35] CHANDRASEKAR B, SMITH JB, FREEMAN GL. Ischemia- reperfusion of rat myocardium activates nuclear factor-KappaB and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine. Circulation. 2001;103(18):2296-2302.
[36] HORCKMANS M, RING L, DUCHENE J, et al. Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype. Eur Heart J. 2017;38(3):187-197.
[37] SHINDE AV, FRANGOGIANNIS NG. Fibroblasts in myocardial infarction: a role in inflammation and repair. J Mol Cell Cardiol. 2014; 70:74-82.
[38] KAIN V, PRABHU SD, HALADE GV. Inflammation revisited: inflammation versus resolution of inflammation following myocardial infarction. Basic Res Cardiol. 2014;109(6):444.
[39] ZHAO J, LI X, HU J, et al. Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization. Cardiovasc Res. 2019; 115(7):1205-1216.
[40] FRANÇOIS M, ROMIEU-MOUREZ R, LI M, et al. Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. Mol Ther. 2012;20(1):187-195.
[41] LIU L, JIN X, HU CF, et al. Exosomes Derived from Mesenchymal Stem Cells Rescue Myocardial Ischaemia/Reperfusion Injury by Inducing Cardiomyocyte Autophagy Via AMPK and Akt Pathways. Cell Physiol Biochem. 2017;43(1):52-68.
[42] WANG X, GU H, QIN D, et al. Exosomal miR-223 Contributes to Mesenchymal Stem Cell-Elicited Cardioprotection in Polymicrobial Sepsis. Sci Rep. 2015;5:13721.
[43] HUANG P, WANG L, LI Q, et al. Atorvastatin Enhances the Therapeutic Efficacy of Mesenchymal Stem Cells Derived Exosomes in Acute Myocardial Infarction via Up-regulating Long Non-coding RNA H19. Cardiovasc Res. 2019 May 22. doi: 10.1093/cvr/cvz139. [Epub ahead of print]
[44] HOFMANN P, SOMMER J, THEODOROU K, et al. Long non-coding RNA H19 regulates endothelial cell aging via inhibition of STAT3 signalling. Cardiovasc Res. 2019;115(1):230-242.
[45] ZHAO Y, SUN X, CAO W, et al. Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Relieve Acute Myocardial Ischemic Injury. Stem Cells Int. 2015;2015:761643.
[46] WANG XL, ZHAO YY, SUN L, et al. Exosomes derived from human umbilical cord mesenchymal stem cells improve myocardial repair via upregulation of Smad7. Int J Mol Med. 2018;41(5):3063-3072.
[47] MA J, ZHAO Y, SUN L, et al. Exosomes Derived from Akt-Modified Human Umbilical Cord Mesenchymal Stem Cells Improve Cardiac Regeneration and Promote Angiogenesis via Activating Platelet- Derived Growth Factor D. Stem Cells Transl Med. 2017;6(1):51-59.
[48] SHI Y, YANG Y, GUO Q, et al. Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Promote Fibroblast-to- Myofibroblast Differentiation in Inflammatory Environments and Benefit Cardioprotective Effects. Stem Cells Dev. 2019;28(12):799-811.
[49] LIU H, SUN X, GONG X, et al. Human umbilical cord mesenchymal stem cells derived exosomes exert antiapoptosis effect via activating PI3K/Akt/mTOR pathway on H9C2 cells. J Cell Biochem. 2019; 120(9): 14455-14464.
[50] CUI GH, WU J, MOU FF, et al. Exosomes derived from hypoxia-preconditioned mesenchymal stromal cells ameliorate cognitive decline by rescuing synaptic dysfunction and regulating inflammatory responses in APP/PS1 mice. FASEB J. 2018;32(2): 654-668.
[51] ZHU J, LU K, ZHANG N, et al. Myocardial reparative functions of exosomes from mesenchymal stem cells are enhanced by hypoxia treatment of the cells via transferring microRNA-210 in an nSMase2-dependent way. Artif Cells Nanomed Biotechnol. 2018; 46(8):1659-1670.
[52] ZHU LP, TIAN T, WANG JY, et al. Hypoxia-elicited mesenchymal stem cell-derived exosomes facilitates cardiac repair through miR-125b-mediated prevention of cell death in myocardial infarction. Theranostics. 2018;8(22):6163-6177.
[53] HAN Y, REN J, BAI Y, et al. Exosomes from hypoxia-treated human adipose-derived mesenchymal stem cells enhance angiogenesis through VEGF/VEGF-R. Int J Biochem Cell Biol. 2019;109:59-68.
[54] CUI X, HE Z, LIANG Z, et al. Exosomes From Adipose-derived Mesenchymal Stem Cells Protect the Myocardium Against Ischemia/Reperfusion Injury Through Wnt/β-Catenin Signaling Pathway. J Cardiovasc Pharmacol. 2017;70(4):225-231.
[55] DENG S, ZHOU X, GE Z, et al. Exosomes from adipose-derived mesenchymal stem cells ameliorate cardiac damage after myocardial infarction by activating S1P/SK1/S1PR1 signaling and promoting macrophage M2 polarization. Int J Biochem Cell Biol. 2019;114: 105564.
[56] WANG K, JIANG Z, WEBSTER KA, et al. Enhanced Cardioprotection by Human Endometrium Mesenchymal Stem Cells Driven by Exosomal MicroRNA-21. Stem Cells Transl Med. 2017;6(1):209-222.
[57] LAFLAMME MA, CHEN KY, NAUMOVA AV, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol. 2007;25(9): 1015-1024.
[58] CHONG JJ, YANG X, DON CW, et al. Human embryonic-stem- cell-derived cardiomyocytes regenerate non-human primate hearts. Nature. 2014;510(7504):273-277.
[59] TAVAKOLI DARGANI Z, SINGLA DK. Embryonic stem cell-derived exosomes inhibit doxorubicin-induced TLR4-NLRP3-mediated cell death-pyroptosis. Am J Physiol Heart Circ Physiol. 2019;317(2): H460-H471.
[60] KHAN M, NICKOLOFF E, ABRAMOVA T, et al. Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction. Circ Res. 2015;117(1):52-64.
[61] WANG Y, MELTON C, LI YP, et al. miR-294/miR-302 promotes proliferation, suppresses G1-S restriction point, and inhibits ESC differentiation through separable mechanisms. Cell Rep. 2013;4(1): 99-109.
[62] GUO WT, WANG XW, YAN YL, et al. Suppression of epithelial-mesenchymal transition and apoptotic pathways by miR-294/302 family synergistically blocks let-7-induced silencing of self-renewal in embryonic stem cells. Cell Death Differ. 2015;22(7): 1158-1169.
[63] LAI RC, ARSLAN F, LEE MM, et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 2010;4(3):214-222.
[64] KERVADEC A, BELLAMY V, EL HARANE N, et al. Cardiovascular progenitor-derived extracellular vesicles recapitulate the beneficial effects of their parent cells in the treatment of chronic heart failure. J Heart Lung Transplant. 2016;35(6):795-807.
[65] TAKAHASHI K, YAMANAKA S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663-676.
[66] TAKAHASHI K, TANABE K, OHNUKI M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131(5):861-872.
[67] SINGLA DK, LONG X, GLASS C, et al. Induced pluripotent stem (iPS) cells repair and regenerate infarcted myocardium. Mol Pharm. 2011; 8(5):1573-1581.
[68] ADAMIAK M, CHENG G, BOBIS-WOZOWICZ S, et al. Induced Pluripotent Stem Cell (iPSC)-Derived Extracellular Vesicles Are Safer and More Effective for Cardiac Repair Than iPSCs. Circ Res. 2018; 122(2):296-309.
[69] WANG Y, ZHANG L, LI Y, et al. Exosomes/microvesicles from induced pluripotent stem cells deliver cardioprotective miRNAs and prevent cardiomyocyte apoptosis in the ischemic myocardium. Int J Cardiol. 2015;192:61-69.
[70] ZHU H, FAN GC. Role of microRNAs in the reperfused myocardium towards post-infarct remodelling. Cardiovasc Res. 2012;94(2): 284-292.
[71] XIAO J, PAN Y, LI XH, et al. Cardiac progenitor cell-derived exosomes prevent cardiomyocytes apoptosis through exosomal miR-21 by targeting PDCD4. Cell Death Dis. 2016;7(6):e2277.
[72] DIAO H, LIU B, SHI Y, et al. MicroRNA-210 alleviates oxidative stress-associated cardiomyocyte apoptosis by regulating BNIP3. Biosci Biotechnol Biochem. 2017;81(9):1712-1720.
[73] YANG PC. Induced Pluripotent Stem Cell (iPSC)-Derived Exosomes for Precision Medicine in Heart Failure. Circ Res. 2018;122(5): 661-663.
[74] EL HARANE N, KERVADEC A, BELLAMY V, et al. Acellular therapeutic approach for heart failure: in vitro production of extracellular vesicles from human cardiovascular progenitors. Eur Heart J. 2018;39(20):1835-1847.
[75] HU GW, LI Q, NIU X, et al. Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells attenuate limb ischemia by promoting angiogenesis in mice. Stem Cell Res Ther. 2015;6:10.
[76] ZHANG J, GUAN J, NIU X, et al. Exosomes released from human induced pluripotent stem cells-derived MSCs facilitate cutaneous wound healing by promoting collagen synthesis and angiogenesis. J Transl Med. 2015;13:49.
[77] YU B, KIM HW, GONG M, et al. Exosomes secreted from GATA-4 overexpressing mesenchymal stem cells serve as a reservoir of anti-apoptotic microRNAs for cardioprotection. Int J Cardiol. 2015; 182:349-360.
[78] KHAN M, NICKOLOFF E, ABRAMOVA T, et al. Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction. Circ Res. 2015;117(1):52-64.
[79] ZHU W, HUANG L, LI Y, et al. Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo. Cancer Lett. 2012;315(1):28-37.
[80] SUN L, XU R, SUN X, et al. Safety evaluation of exosomes derived from human umbilical cord mesenchymal stromal cell. Cytotherapy. 2016;18(3):413-422.
[81] ADAMIAK M, CHENG G, BOBIS-WOZOWICZ S, et al. Induced Pluripotent Stem Cell (iPSC)-Derived Extracellular Vesicles Are Safer and More Effective for Cardiac Repair Than iPSCs. Circ Res. 2018; 122(2):296-309.
|